modified particle point analysis script Search Results


95
Chem Impex International alginate particles
Alginate Particles, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+particle+point+analysis+script/Alginic+acid+sodium+salt%2C+low+viscosity/pm26939998-162-7-16
Average 95 stars, based on 1 article reviews
alginate particles - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

97
Miltenyi Biotec human cd34 microbead kit
a, Schema for analysis of BM primitive SLAM LSK HSPCs. Murine femurs and tibias were harvested, flushed, and crushed, to collect maximal yield of bone and marrow cells. BM labeled cells were flow sorted for the SLAM LSK markers: Live\Ter-119 neg \Lineage neg \Sca-1 + \c-Kit + \CD150 + \CD48 neg . Next, combined multiome single-nuclei RNA/ATAC (snRNA/ATAC) sequencing analysis was performed. b, Weighted nearest neighbor (WNN) UMAP with hematopoietic stem and <t>progenitor</t> <t>cell</t> type annotation for hematopoietic <t>stem</t> <t>cell</t> (HSC), multi-potent progenitor (MPP), megakaryocyte progenitor (MkP), and erythrocyte progenitor (EryP) sub-cluster representation. c, Engrafting LTR-HSC transcriptional signature (from Rodriguez-Fraiticelli et al . 2020) assigned on a WNN UMAP space. d, Heatmap representation of differential transcriptional nuclei output from distinct HSPC sub-clusters by averaged Z-score, with selected genes presented. e, Heatmap representation of differential ChromVAR motif activity in distinct HSPC sub-clusters by averaged Z-score, with selected TF motifs presented.
Human Cd34 Microbead Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+particle+point+analysis+script/CD34+MicroBead+Kit%2C+human/bio_rxiv__2023__03__27__534417-305-19-23
Average 97 stars, based on 1 article reviews
human cd34 microbead kit - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

90
Particle Measuring Systems Inc pcasp probe
a, Schema for analysis of BM primitive SLAM LSK HSPCs. Murine femurs and tibias were harvested, flushed, and crushed, to collect maximal yield of bone and marrow cells. BM labeled cells were flow sorted for the SLAM LSK markers: Live\Ter-119 neg \Lineage neg \Sca-1 + \c-Kit + \CD150 + \CD48 neg . Next, combined multiome single-nuclei RNA/ATAC (snRNA/ATAC) sequencing analysis was performed. b, Weighted nearest neighbor (WNN) UMAP with hematopoietic stem and <t>progenitor</t> <t>cell</t> type annotation for hematopoietic <t>stem</t> <t>cell</t> (HSC), multi-potent progenitor (MPP), megakaryocyte progenitor (MkP), and erythrocyte progenitor (EryP) sub-cluster representation. c, Engrafting LTR-HSC transcriptional signature (from Rodriguez-Fraiticelli et al . 2020) assigned on a WNN UMAP space. d, Heatmap representation of differential transcriptional nuclei output from distinct HSPC sub-clusters by averaged Z-score, with selected genes presented. e, Heatmap representation of differential ChromVAR motif activity in distinct HSPC sub-clusters by averaged Z-score, with selected TF motifs presented.
Pcasp Probe, supplied by Particle Measuring Systems Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+particle+point+analysis+script/pcasp+probe/10__1029_slash_2019jd031159-60-8-10
Average 90 stars, based on 1 article reviews
pcasp probe - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

99
Thermo Fisher glucose dulbecco
a, Schema for analysis of BM primitive SLAM LSK HSPCs. Murine femurs and tibias were harvested, flushed, and crushed, to collect maximal yield of bone and marrow cells. BM labeled cells were flow sorted for the SLAM LSK markers: Live\Ter-119 neg \Lineage neg \Sca-1 + \c-Kit + \CD150 + \CD48 neg . Next, combined multiome single-nuclei RNA/ATAC (snRNA/ATAC) sequencing analysis was performed. b, Weighted nearest neighbor (WNN) UMAP with hematopoietic stem and <t>progenitor</t> <t>cell</t> type annotation for hematopoietic <t>stem</t> <t>cell</t> (HSC), multi-potent progenitor (MPP), megakaryocyte progenitor (MkP), and erythrocyte progenitor (EryP) sub-cluster representation. c, Engrafting LTR-HSC transcriptional signature (from Rodriguez-Fraiticelli et al . 2020) assigned on a WNN UMAP space. d, Heatmap representation of differential transcriptional nuclei output from distinct HSPC sub-clusters by averaged Z-score, with selected genes presented. e, Heatmap representation of differential ChromVAR motif activity in distinct HSPC sub-clusters by averaged Z-score, with selected TF motifs presented.
Glucose Dulbecco, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+particle+point+analysis+script/D(%2B)-Glucose/pmc04580499-71-12-18
Average 99 stars, based on 1 article reviews
glucose dulbecco - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

90
Metabion International AG phosphorothioate-modified odns
a, Schema for analysis of BM primitive SLAM LSK HSPCs. Murine femurs and tibias were harvested, flushed, and crushed, to collect maximal yield of bone and marrow cells. BM labeled cells were flow sorted for the SLAM LSK markers: Live\Ter-119 neg \Lineage neg \Sca-1 + \c-Kit + \CD150 + \CD48 neg . Next, combined multiome single-nuclei RNA/ATAC (snRNA/ATAC) sequencing analysis was performed. b, Weighted nearest neighbor (WNN) UMAP with hematopoietic stem and <t>progenitor</t> <t>cell</t> type annotation for hematopoietic <t>stem</t> <t>cell</t> (HSC), multi-potent progenitor (MPP), megakaryocyte progenitor (MkP), and erythrocyte progenitor (EryP) sub-cluster representation. c, Engrafting LTR-HSC transcriptional signature (from Rodriguez-Fraiticelli et al . 2020) assigned on a WNN UMAP space. d, Heatmap representation of differential transcriptional nuclei output from distinct HSPC sub-clusters by averaged Z-score, with selected genes presented. e, Heatmap representation of differential ChromVAR motif activity in distinct HSPC sub-clusters by averaged Z-score, with selected TF motifs presented.
Phosphorothioate Modified Odns, supplied by Metabion International AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+particle+point+analysis+script/completely+partially+phosphorothioate+modified+oligodeoxynucleotides++odns/pmc04523003-238-3-7
Average 90 stars, based on 1 article reviews
phosphorothioate-modified odns - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

99
New England Biolabs resource source identifier speedbeads magnetic carboxylate modified particles cytive life sciences
a, Schema for analysis of BM primitive SLAM LSK HSPCs. Murine femurs and tibias were harvested, flushed, and crushed, to collect maximal yield of bone and marrow cells. BM labeled cells were flow sorted for the SLAM LSK markers: Live\Ter-119 neg \Lineage neg \Sca-1 + \c-Kit + \CD150 + \CD48 neg . Next, combined multiome single-nuclei RNA/ATAC (snRNA/ATAC) sequencing analysis was performed. b, Weighted nearest neighbor (WNN) UMAP with hematopoietic stem and <t>progenitor</t> <t>cell</t> type annotation for hematopoietic <t>stem</t> <t>cell</t> (HSC), multi-potent progenitor (MPP), megakaryocyte progenitor (MkP), and erythrocyte progenitor (EryP) sub-cluster representation. c, Engrafting LTR-HSC transcriptional signature (from Rodriguez-Fraiticelli et al . 2020) assigned on a WNN UMAP space. d, Heatmap representation of differential transcriptional nuclei output from distinct HSPC sub-clusters by averaged Z-score, with selected genes presented. e, Heatmap representation of differential ChromVAR motif activity in distinct HSPC sub-clusters by averaged Z-score, with selected TF motifs presented.
Resource Source Identifier Speedbeads Magnetic Carboxylate Modified Particles Cytive Life Sciences, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+particle+point+analysis+script/DNase+I/pm39612916-274-2-20
Average 99 stars, based on 1 article reviews
resource source identifier speedbeads magnetic carboxylate modified particles cytive life sciences - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

98
Miltenyi Biotec cd14 microbeads
a, Schema for analysis of BM primitive SLAM LSK HSPCs. Murine femurs and tibias were harvested, flushed, and crushed, to collect maximal yield of bone and marrow cells. BM labeled cells were flow sorted for the SLAM LSK markers: Live\Ter-119 neg \Lineage neg \Sca-1 + \c-Kit + \CD150 + \CD48 neg . Next, combined multiome single-nuclei RNA/ATAC (snRNA/ATAC) sequencing analysis was performed. b, Weighted nearest neighbor (WNN) UMAP with hematopoietic stem and <t>progenitor</t> <t>cell</t> type annotation for hematopoietic <t>stem</t> <t>cell</t> (HSC), multi-potent progenitor (MPP), megakaryocyte progenitor (MkP), and erythrocyte progenitor (EryP) sub-cluster representation. c, Engrafting LTR-HSC transcriptional signature (from Rodriguez-Fraiticelli et al . 2020) assigned on a WNN UMAP space. d, Heatmap representation of differential transcriptional nuclei output from distinct HSPC sub-clusters by averaged Z-score, with selected genes presented. e, Heatmap representation of differential ChromVAR motif activity in distinct HSPC sub-clusters by averaged Z-score, with selected TF motifs presented.
Cd14 Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+particle+point+analysis+script/CD14+MicroBeads%2C+human/pm40763837-64-10-13
Average 98 stars, based on 1 article reviews
cd14 microbeads - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

94
Miltenyi Biotec anti a2b5 microbeads
a, Schema for analysis of BM primitive SLAM LSK HSPCs. Murine femurs and tibias were harvested, flushed, and crushed, to collect maximal yield of bone and marrow cells. BM labeled cells were flow sorted for the SLAM LSK markers: Live\Ter-119 neg \Lineage neg \Sca-1 + \c-Kit + \CD150 + \CD48 neg . Next, combined multiome single-nuclei RNA/ATAC (snRNA/ATAC) sequencing analysis was performed. b, Weighted nearest neighbor (WNN) UMAP with hematopoietic stem and <t>progenitor</t> <t>cell</t> type annotation for hematopoietic <t>stem</t> <t>cell</t> (HSC), multi-potent progenitor (MPP), megakaryocyte progenitor (MkP), and erythrocyte progenitor (EryP) sub-cluster representation. c, Engrafting LTR-HSC transcriptional signature (from Rodriguez-Fraiticelli et al . 2020) assigned on a WNN UMAP space. d, Heatmap representation of differential transcriptional nuclei output from distinct HSPC sub-clusters by averaged Z-score, with selected genes presented. e, Heatmap representation of differential ChromVAR motif activity in distinct HSPC sub-clusters by averaged Z-score, with selected TF motifs presented.
Anti A2b5 Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+particle+point+analysis+script/Anti-A2B5+MicroBeads%2C+human%2C+mouse/pm29400711-939-30-34
Average 94 stars, based on 1 article reviews
anti a2b5 microbeads - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Miltenyi Biotec cd117 microbead kit

Cd117 Microbead Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+particle+point+analysis+script/CD117+MicroBead+Kit%2C+human/pmc11024925-125-0-5
Average 96 stars, based on 1 article reviews
cd117 microbead kit - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

90
Eiken Chemical dried plate for antifungal susceptibility testing

Dried Plate For Antifungal Susceptibility Testing, supplied by Eiken Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+particle+point+analysis+script/dried+plate+for+antifungal+susceptibility+testing/10__1128_slash_aac__02583___16-42-34-40
Average 90 stars, based on 1 article reviews
dried plate for antifungal susceptibility testing - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

91
OriGene human ace2
Anti-S Neutralizing Antibody Titers Decrease over Time Pseudoviral particles coding for the luciferase reporter gene and bearing the glycoproteins SARS-CoV-2 S (A, D, G, and H), SARS-CoV S (B, E, and I), or VSV-G (C and F) were used to infect <t>293T-ACE2</t> cells. Pseudoviruses were incubated with serial dilutions of samples from 10 COVID-19-negative or 106 COVID-19-positive patients (T1, T2, T3, T4, and convalescent) at 37°C for 1 h prior to infection of 293T-ACE2 cells. Infectivity at each dilution was assessed in duplicate and is shown as the percentage of infection without sera for each glycoprotein. Neutralization half maximal inhibitory serum dilution (ID 50 ) (G and I) and ID 80 (H) values were determined using a normalized non-linear regression using GraphPad Prism software. Undetectable measures are represented as white symbols. Neutralizer represent patients with an ID 50 over 100 (G and I) or an ID 80 (H). Statistical significance was tested using Mann-Whitney U tests (∗p < 0.05; ∗∗p < 0.01).
Human Ace2, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+particle+point+analysis+script/ACE2+(NM_021804)+Human+Tagged+ORF+Clone+Lentiviral+Particle/pmc07524645-190-23-26
Average 91 stars, based on 1 article reviews
human ace2 - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology sp3
FIG. 3. <t>Sp1/Sp3</t> binds 149- to 124-bp region of the Glut 3 gene. Mobility shift assays were carried out as explained under “Ex- perimental Procedures.” A, mobility shift assay. 32P-Labeled 149- to 124-bp GLUT 3 oligonucleotide (lane 1) was incubated with 5 g of nuclear extracts from N2A cells (lanes 2–4) and 1-day (1d) (lanes 5–7) and 21-day (21d) mouse brain nuclear extracts (lanes 8–10) and sub- jected to electrophoresis followed by autoradiography. The Sp1/Sp3 band shifts are shown. Addition of the anti-Sp1 antibody (lanes 3, 6, and 9) and anti-Sp3 antibody (lanes 4, 7, and 10) caused the supershift as shown. B, Western blot analysis. Presence of Sp1/Sp3 in these nuclear extracts is shown by Western blot analysis. Nuclear extracts (30 g) from N2A cells and 1- and 21-day-old mouse brain were subjected to immunoblot analysis as explained under “Experimental Procedures.” A representative blot showing a 105-kDa Sp1 protein (top panel) and 97- and 60-kDa bands for Sp3 (lower panel) is presented here. C, Sp1/Sp3 binding to 149 to 124 bp of the Glut 3 gene requires post-transla- tional modification. Mouse brain nuclear extracts from 1- and 21-day- old animals were used in mobility shift assays with the Sp1 consensus sequence (Promega) as probe (lanes 1 and 2). Lanes 3–7 contain the 149 to 119 bp (GT3 SP1). Binding reactions carried out using 1- and 21-day-old mouse brain nuclear extracts and human recombinant Sp1 (Promega) are shown in lanes 3–5 in respective order. Mixing experi- ments of the human recombinant Sp1 and nuclear extracts from 1- and 21-day-old mouse brain are shown in lanes 6 and 7.
Sp3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+particle+point+analysis+script/Sp3+Lentiviral+Activation+Particles/10__1074_slash_jbc__m402735200-121-14-15
Average 93 stars, based on 1 article reviews
sp3 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


a, Schema for analysis of BM primitive SLAM LSK HSPCs. Murine femurs and tibias were harvested, flushed, and crushed, to collect maximal yield of bone and marrow cells. BM labeled cells were flow sorted for the SLAM LSK markers: Live\Ter-119 neg \Lineage neg \Sca-1 + \c-Kit + \CD150 + \CD48 neg . Next, combined multiome single-nuclei RNA/ATAC (snRNA/ATAC) sequencing analysis was performed. b, Weighted nearest neighbor (WNN) UMAP with hematopoietic stem and progenitor cell type annotation for hematopoietic stem cell (HSC), multi-potent progenitor (MPP), megakaryocyte progenitor (MkP), and erythrocyte progenitor (EryP) sub-cluster representation. c, Engrafting LTR-HSC transcriptional signature (from Rodriguez-Fraiticelli et al . 2020) assigned on a WNN UMAP space. d, Heatmap representation of differential transcriptional nuclei output from distinct HSPC sub-clusters by averaged Z-score, with selected genes presented. e, Heatmap representation of differential ChromVAR motif activity in distinct HSPC sub-clusters by averaged Z-score, with selected TF motifs presented.

Journal: bioRxiv

Article Title: Transcriptional Activation of Regenerative Hematopoiesis via Vascular Niche Sensing

doi: 10.1101/2023.03.27.534417

Figure Lengend Snippet: a, Schema for analysis of BM primitive SLAM LSK HSPCs. Murine femurs and tibias were harvested, flushed, and crushed, to collect maximal yield of bone and marrow cells. BM labeled cells were flow sorted for the SLAM LSK markers: Live\Ter-119 neg \Lineage neg \Sca-1 + \c-Kit + \CD150 + \CD48 neg . Next, combined multiome single-nuclei RNA/ATAC (snRNA/ATAC) sequencing analysis was performed. b, Weighted nearest neighbor (WNN) UMAP with hematopoietic stem and progenitor cell type annotation for hematopoietic stem cell (HSC), multi-potent progenitor (MPP), megakaryocyte progenitor (MkP), and erythrocyte progenitor (EryP) sub-cluster representation. c, Engrafting LTR-HSC transcriptional signature (from Rodriguez-Fraiticelli et al . 2020) assigned on a WNN UMAP space. d, Heatmap representation of differential transcriptional nuclei output from distinct HSPC sub-clusters by averaged Z-score, with selected genes presented. e, Heatmap representation of differential ChromVAR motif activity in distinct HSPC sub-clusters by averaged Z-score, with selected TF motifs presented.

Article Snippet: Human hematopoietic CD34 + HSPCs from either cord blood (CB) or mobilized peripheral blood (mPB) donors, were isolated using human CD34 microbead kit (Miltenyi Biotec) and by passing twice through LS columns (Miltenyi Biotec) attached to a magnetic stand, achieving a purity >95%.

Techniques: Labeling, Sequencing, Activity Assay

WT, Fli-1 ROSAΔ , and Fli-1 ROSAΔ with conditionally inducible Notch1 internal component overexpression transgene (Fli-1 ROSAΔ N1-IC iOE ) BM LSK HSPCs were isolated and expanded as described in Fig. S5A. Harvested cells were analyzed by flow cytometry and/or flow sorted for LSK HSPCs which were competitively co-transplanted with congenic SJL BM cells into lethally irradiated congenic SJL recipient mice. a, Representative images of co-cultures at the end point before harvest. Yellow arrows indicate megakaryocytes. Note expansion of round hematopoietic cells in Fli-1 ROSAΔ N1-IC iOE co-cultures without any appearance of megakaryocytes. Bar = 100 µM. b, Frequency of LSK HSPCs was determined by flow cytometry and fold expansion was calculated. One-way ANOVA multiple comparisons was used; n=4 BM donor mice per genotype, with 2 technical replicates per donor. c, Frequency of chimerism indicating engraftment levels as determined by flow cytometry. One-way ANOVA multiple comparisons was used; n=8 recipient mice per genotype. d-g, WT, Fli-1 ROSAΔ , and Fli-1 ROSAΔ with conditionally inducible Notch1 internal component overexpression transgene (Fli-1 ROSAΔ N1-IC iOE ) BM LSK HSPCs were isolated and expanded. After 48 hours of expansion in co-culture, cells were harvested and hematopoietic LSK HSPCs were sorted and applied for single cell RNA-seq analysis; n=4 per genotype “pooled” together. d, Dimensionality reduction by UMAP of single cell transcriptomes from co-cultured and sorted LSK HSPCs. e. Dot plot for the E-SLAM HSC markers EPCR, CD34, and CD150 per cluster identity. Dot plot size indicates percent expression in cluster and color intensity indicates average expression score. f. Distribution of clusters 7 and 15 in UMAP for HSC identified populations among LSK HSPC clusters based on Garnette and the Dot plot from panel (e). g, Dot plot for cell cycle scores (S phase and G2/M phases) per cluster identity. Dot plot size indicates percent expression in cluster and color intensity indicates average expression score. h, Cell cycle status classification in UMAP for clusters 7 and 15: WT (left UMAP), Fli-1 ROSAΔ (middle UMAP) and Fli1 ROSAΔ N1-IC iOE (right UMAP). i-l, BM cells were harvested, 16 weeks post engraftment of WT and “rescued” Fli-1 ROSAΔ N1-IC iOE long term repopulating HSCs and pooled from n=4 recipient mice (from 4 different donors) per genotype. CD45.2 + /Lin − cells were flow sorted and applied for single cell RNA-seq analysis. (HSC: hematopoietic stem cells, MPP: multi-potent progenitors, LPP: lymphoid-primed progenitors, MEP: megakaryocyte/erythroid progenitors). i, Dimensionality reduction by UMAP of single cell transcriptomes from donor-derived lineage-negative BM samples (CD45.2 + /Lin − ) following transplantation of WT or Fli1 ROSAΔ N1-IC iOE LSK HSPC. j, Cell type classification of hematopoietic sub-populations using Garnette: WT (left panel) and Fli1 ROSAΔ N1-IC iOE (right panel) samples in UMAP, and distribution of cell types between samples (bar plot). k, Distribution of WT and Fli1 ROSAΔ N1-IC iOE sample cells in UMAP among populations classified as multi-lineage stem/progenitor cell types (HSC, MPP, or LPP) using Garnette, and distribution of cell types between samples (bar plot). See also Table S5. l , Heatmaps of gene-set scores for the subset of multi-lineage stem and progenitor cell types (HSC, MPP, LPP) in UMAP (left panels), and violin plots of gene-set scores between samples (WT vs Fli1 ROSAΔ N1-IC iOE ) (right panels), for HSC molecular overlap signature genes (from Wilson et al . 2015) and engrafting long term HSC signature genes (from Rodriguez-Fraiticelli et al . 2020). Gene-set scores in violin plots are shown only for the subset of cells classified as HSC cell type. Wilcoxon Rank Sum Test was used to determine p-Values.

Journal: bioRxiv

Article Title: Transcriptional Activation of Regenerative Hematopoiesis via Vascular Niche Sensing

doi: 10.1101/2023.03.27.534417

Figure Lengend Snippet: WT, Fli-1 ROSAΔ , and Fli-1 ROSAΔ with conditionally inducible Notch1 internal component overexpression transgene (Fli-1 ROSAΔ N1-IC iOE ) BM LSK HSPCs were isolated and expanded as described in Fig. S5A. Harvested cells were analyzed by flow cytometry and/or flow sorted for LSK HSPCs which were competitively co-transplanted with congenic SJL BM cells into lethally irradiated congenic SJL recipient mice. a, Representative images of co-cultures at the end point before harvest. Yellow arrows indicate megakaryocytes. Note expansion of round hematopoietic cells in Fli-1 ROSAΔ N1-IC iOE co-cultures without any appearance of megakaryocytes. Bar = 100 µM. b, Frequency of LSK HSPCs was determined by flow cytometry and fold expansion was calculated. One-way ANOVA multiple comparisons was used; n=4 BM donor mice per genotype, with 2 technical replicates per donor. c, Frequency of chimerism indicating engraftment levels as determined by flow cytometry. One-way ANOVA multiple comparisons was used; n=8 recipient mice per genotype. d-g, WT, Fli-1 ROSAΔ , and Fli-1 ROSAΔ with conditionally inducible Notch1 internal component overexpression transgene (Fli-1 ROSAΔ N1-IC iOE ) BM LSK HSPCs were isolated and expanded. After 48 hours of expansion in co-culture, cells were harvested and hematopoietic LSK HSPCs were sorted and applied for single cell RNA-seq analysis; n=4 per genotype “pooled” together. d, Dimensionality reduction by UMAP of single cell transcriptomes from co-cultured and sorted LSK HSPCs. e. Dot plot for the E-SLAM HSC markers EPCR, CD34, and CD150 per cluster identity. Dot plot size indicates percent expression in cluster and color intensity indicates average expression score. f. Distribution of clusters 7 and 15 in UMAP for HSC identified populations among LSK HSPC clusters based on Garnette and the Dot plot from panel (e). g, Dot plot for cell cycle scores (S phase and G2/M phases) per cluster identity. Dot plot size indicates percent expression in cluster and color intensity indicates average expression score. h, Cell cycle status classification in UMAP for clusters 7 and 15: WT (left UMAP), Fli-1 ROSAΔ (middle UMAP) and Fli1 ROSAΔ N1-IC iOE (right UMAP). i-l, BM cells were harvested, 16 weeks post engraftment of WT and “rescued” Fli-1 ROSAΔ N1-IC iOE long term repopulating HSCs and pooled from n=4 recipient mice (from 4 different donors) per genotype. CD45.2 + /Lin − cells were flow sorted and applied for single cell RNA-seq analysis. (HSC: hematopoietic stem cells, MPP: multi-potent progenitors, LPP: lymphoid-primed progenitors, MEP: megakaryocyte/erythroid progenitors). i, Dimensionality reduction by UMAP of single cell transcriptomes from donor-derived lineage-negative BM samples (CD45.2 + /Lin − ) following transplantation of WT or Fli1 ROSAΔ N1-IC iOE LSK HSPC. j, Cell type classification of hematopoietic sub-populations using Garnette: WT (left panel) and Fli1 ROSAΔ N1-IC iOE (right panel) samples in UMAP, and distribution of cell types between samples (bar plot). k, Distribution of WT and Fli1 ROSAΔ N1-IC iOE sample cells in UMAP among populations classified as multi-lineage stem/progenitor cell types (HSC, MPP, or LPP) using Garnette, and distribution of cell types between samples (bar plot). See also Table S5. l , Heatmaps of gene-set scores for the subset of multi-lineage stem and progenitor cell types (HSC, MPP, LPP) in UMAP (left panels), and violin plots of gene-set scores between samples (WT vs Fli1 ROSAΔ N1-IC iOE ) (right panels), for HSC molecular overlap signature genes (from Wilson et al . 2015) and engrafting long term HSC signature genes (from Rodriguez-Fraiticelli et al . 2020). Gene-set scores in violin plots are shown only for the subset of cells classified as HSC cell type. Wilcoxon Rank Sum Test was used to determine p-Values.

Article Snippet: Human hematopoietic CD34 + HSPCs from either cord blood (CB) or mobilized peripheral blood (mPB) donors, were isolated using human CD34 microbead kit (Miltenyi Biotec) and by passing twice through LS columns (Miltenyi Biotec) attached to a magnetic stand, achieving a purity >95%.

Techniques: Over Expression, Isolation, Flow Cytometry, Irradiation, Co-Culture Assay, RNA Sequencing, Cell Culture, Expressing, Derivative Assay, Transplantation Assay

a-d, Sorted CD45 + /CD34 + HSPC from cord blood (CB) and adult mobilized peripheral blood (mPB) sources, were co-cultured on top of a vascular niche for 48h to encourage HSPC activation. Next, cells were harvested and CD45 + /CD34 + HSPC were sorted and applied for single cell RNA-seq analysis. a-c, Dimensionality reduction by UMAP of single cell transcriptomes from co-cultured and sorted CD45 + /CD34 + HSPC, displaying cell distribution by CB and mPB source (a), cluster identity (b), and single cell cycle phase (c). d, Dot plot for cell cycle scores (S phase and G2/M phases) per cellular source (CB or mPB), for total cells in analysis (upper panel) and for HSC\MPP cluster (lower panel). Dot plot size indicates percent expression in cluster and color intensity indicates average expression score. e, To highly enrich for HSCs, the mononuclear fraction from CB (n=3) and mPB (n=4) sources was isolated, labeled, and sorted for CD45 + /CD34 + /CD38 − /CD45RA − /CD90 + /CD49f + . Sorted cells were lysed and processed for RNAseq analysis. GSEA analysis plots for HSC activation signatures (left panels) and for HSC quiescence signatures (right panels) acquired from Venezia et al., 2004 (upper panels) and from Roy et al., 2021 (lower panels), showing a positive enrichment for the activation signatures in CB HSCs and positive enrichment for quiescence signatures in mPB HSCs. f, g, UMAP projections of the single cell ATAC-seq enrichment analysis for sorted HSPCs of all 10 signatures identified in Takayama et al., 2021. Colors indicate the degree of enrichment in each cell (blue, depleted; red, enriched). Scale bar indicates enrichment Z-score. f, Enrichment for activated HSPCs (upper panel) and quiescent HSPCs (lower panel) signatures defined in in Takayama et al., 2021., as calculated by chromVAR. g, Enrichment for called peaks from the FLI-1 HSPC ChIP-seq (Fli-1 signature) data set (Beck et al., 2013) overlayed on single cell ATAC-seq HSPC data set (Takayama et al., 2021), as analyzed by chromVAR.

Journal: bioRxiv

Article Title: Transcriptional Activation of Regenerative Hematopoiesis via Vascular Niche Sensing

doi: 10.1101/2023.03.27.534417

Figure Lengend Snippet: a-d, Sorted CD45 + /CD34 + HSPC from cord blood (CB) and adult mobilized peripheral blood (mPB) sources, were co-cultured on top of a vascular niche for 48h to encourage HSPC activation. Next, cells were harvested and CD45 + /CD34 + HSPC were sorted and applied for single cell RNA-seq analysis. a-c, Dimensionality reduction by UMAP of single cell transcriptomes from co-cultured and sorted CD45 + /CD34 + HSPC, displaying cell distribution by CB and mPB source (a), cluster identity (b), and single cell cycle phase (c). d, Dot plot for cell cycle scores (S phase and G2/M phases) per cellular source (CB or mPB), for total cells in analysis (upper panel) and for HSC\MPP cluster (lower panel). Dot plot size indicates percent expression in cluster and color intensity indicates average expression score. e, To highly enrich for HSCs, the mononuclear fraction from CB (n=3) and mPB (n=4) sources was isolated, labeled, and sorted for CD45 + /CD34 + /CD38 − /CD45RA − /CD90 + /CD49f + . Sorted cells were lysed and processed for RNAseq analysis. GSEA analysis plots for HSC activation signatures (left panels) and for HSC quiescence signatures (right panels) acquired from Venezia et al., 2004 (upper panels) and from Roy et al., 2021 (lower panels), showing a positive enrichment for the activation signatures in CB HSCs and positive enrichment for quiescence signatures in mPB HSCs. f, g, UMAP projections of the single cell ATAC-seq enrichment analysis for sorted HSPCs of all 10 signatures identified in Takayama et al., 2021. Colors indicate the degree of enrichment in each cell (blue, depleted; red, enriched). Scale bar indicates enrichment Z-score. f, Enrichment for activated HSPCs (upper panel) and quiescent HSPCs (lower panel) signatures defined in in Takayama et al., 2021., as calculated by chromVAR. g, Enrichment for called peaks from the FLI-1 HSPC ChIP-seq (Fli-1 signature) data set (Beck et al., 2013) overlayed on single cell ATAC-seq HSPC data set (Takayama et al., 2021), as analyzed by chromVAR.

Article Snippet: Human hematopoietic CD34 + HSPCs from either cord blood (CB) or mobilized peripheral blood (mPB) donors, were isolated using human CD34 microbead kit (Miltenyi Biotec) and by passing twice through LS columns (Miltenyi Biotec) attached to a magnetic stand, achieving a purity >95%.

Techniques: Cell Culture, Activation Assay, RNA Sequencing, Expressing, Isolation, Labeling, ChIP-sequencing

a, Schema of experimental design. Sorted human CD34 + HSPCs from cord blood (CB) or mobilized peripheral blood (mPB) sources were transduced by electroporation with FLI-1 modified-RNA molecules (2 µg FLI-1 modRNA per 10 5 cells) and expanded for 1 week on top of E4orf1 vascular niche cells in a sub-optimal ratio of 1:3 (HSPCs:ECs). Next, expansion co-cultures were analyzed and transplanted into immunodeficient NSG KitW41 mice without myeloablative preconditioning. b , Fold expansion of CB derived hematopoietic subtypes after 1 week in co-culture following transduction with FLI-1 (red) or control (blue) modified-RNA. Unpaired two tailed t-test was used; n = 4 CB donors. Each mark represents the averaged triplicate (n = 3 technical repeats) per donor. c , Fold expansion of mPB derived hematopoietic subtypes after 1 week in co-culture following transduction with FLI-1 (red) or control (blue) modified-RNA. Unpaired two tailed t-test was used; n = 4 mPB donors. Each mark represents the averaged triplicate (n = 3 technical repeats) per donor. d, Representative flow dot plots of mPB HSPC analysis post 1 week of expansion in co-culture following transduction with FLI-1 or control modified-RNA. The population of CD34 + \CD38 neg HSPCs is colored in red. e, Human CD45 chimerism analysis in peripheral blood (PB), spleen, and bone marrow (BM) of NSG KitW41 mice. Tissues were harvested and analyzed by flow cytometry 16 weeks post transplantation. Unpaired two tailed t-test was used; n = 6 mPB donors. f, Frequency of BM engrafted human HSPCs as determined by flow cytometry 16 weeks post transplantation. Unpaired two tailed t-test was used; n = 6 mPB donors. g, Representative flow dot plots for BM engrafted human CD34 + and CD34 + \CD38 neg HSPCs acquired 16 weeks post transplantation. Unpaired two tailed t-test was used; n = 6 mPB donors. h, Total BM from primary NSG KitW41 recipient mice was transplanted into secondary NSG KitW41 recipient mice without myeloablative preconditioning. Human CD45 chimerism in the BM of recipient mice was determined by flow cytometry 16 weeks post secondary transplantation. Unpaired two tailed t-test was used; n = 6 mPB donors.

Journal: bioRxiv

Article Title: Transcriptional Activation of Regenerative Hematopoiesis via Vascular Niche Sensing

doi: 10.1101/2023.03.27.534417

Figure Lengend Snippet: a, Schema of experimental design. Sorted human CD34 + HSPCs from cord blood (CB) or mobilized peripheral blood (mPB) sources were transduced by electroporation with FLI-1 modified-RNA molecules (2 µg FLI-1 modRNA per 10 5 cells) and expanded for 1 week on top of E4orf1 vascular niche cells in a sub-optimal ratio of 1:3 (HSPCs:ECs). Next, expansion co-cultures were analyzed and transplanted into immunodeficient NSG KitW41 mice without myeloablative preconditioning. b , Fold expansion of CB derived hematopoietic subtypes after 1 week in co-culture following transduction with FLI-1 (red) or control (blue) modified-RNA. Unpaired two tailed t-test was used; n = 4 CB donors. Each mark represents the averaged triplicate (n = 3 technical repeats) per donor. c , Fold expansion of mPB derived hematopoietic subtypes after 1 week in co-culture following transduction with FLI-1 (red) or control (blue) modified-RNA. Unpaired two tailed t-test was used; n = 4 mPB donors. Each mark represents the averaged triplicate (n = 3 technical repeats) per donor. d, Representative flow dot plots of mPB HSPC analysis post 1 week of expansion in co-culture following transduction with FLI-1 or control modified-RNA. The population of CD34 + \CD38 neg HSPCs is colored in red. e, Human CD45 chimerism analysis in peripheral blood (PB), spleen, and bone marrow (BM) of NSG KitW41 mice. Tissues were harvested and analyzed by flow cytometry 16 weeks post transplantation. Unpaired two tailed t-test was used; n = 6 mPB donors. f, Frequency of BM engrafted human HSPCs as determined by flow cytometry 16 weeks post transplantation. Unpaired two tailed t-test was used; n = 6 mPB donors. g, Representative flow dot plots for BM engrafted human CD34 + and CD34 + \CD38 neg HSPCs acquired 16 weeks post transplantation. Unpaired two tailed t-test was used; n = 6 mPB donors. h, Total BM from primary NSG KitW41 recipient mice was transplanted into secondary NSG KitW41 recipient mice without myeloablative preconditioning. Human CD45 chimerism in the BM of recipient mice was determined by flow cytometry 16 weeks post secondary transplantation. Unpaired two tailed t-test was used; n = 6 mPB donors.

Article Snippet: Human hematopoietic CD34 + HSPCs from either cord blood (CB) or mobilized peripheral blood (mPB) donors, were isolated using human CD34 microbead kit (Miltenyi Biotec) and by passing twice through LS columns (Miltenyi Biotec) attached to a magnetic stand, achieving a purity >95%.

Techniques: Electroporation, Modification, Derivative Assay, Co-Culture Assay, Transduction, Control, Two Tailed Test, Flow Cytometry, Transplantation Assay

Journal: iScience

Article Title: Pharmacological inhibition of RAS overcomes FLT3 inhibitor resistance in FLT3-ITD+ AML through AP-1 and RUNX1

doi: 10.1016/j.isci.2024.109576

Figure Lengend Snippet:

Article Snippet: CD117 MicroBead kit, human , Miltenyi Biotec , 130-091-332.

Techniques: Control, Virus, Recombinant, Modification, Saline, Stripping Membranes, Protease Inhibitor, Reverse Transcription, Membrane, Labeling, Gel Extraction, Plasmid Preparation, RNA Library Preparation, Library Quantification, Software

Anti-S Neutralizing Antibody Titers Decrease over Time Pseudoviral particles coding for the luciferase reporter gene and bearing the glycoproteins SARS-CoV-2 S (A, D, G, and H), SARS-CoV S (B, E, and I), or VSV-G (C and F) were used to infect 293T-ACE2 cells. Pseudoviruses were incubated with serial dilutions of samples from 10 COVID-19-negative or 106 COVID-19-positive patients (T1, T2, T3, T4, and convalescent) at 37°C for 1 h prior to infection of 293T-ACE2 cells. Infectivity at each dilution was assessed in duplicate and is shown as the percentage of infection without sera for each glycoprotein. Neutralization half maximal inhibitory serum dilution (ID 50 ) (G and I) and ID 80 (H) values were determined using a normalized non-linear regression using GraphPad Prism software. Undetectable measures are represented as white symbols. Neutralizer represent patients with an ID 50 over 100 (G and I) or an ID 80 (H). Statistical significance was tested using Mann-Whitney U tests (∗p < 0.05; ∗∗p < 0.01).

Journal: Cell Reports Medicine

Article Title: Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike

doi: 10.1016/j.xcrm.2020.100126

Figure Lengend Snippet: Anti-S Neutralizing Antibody Titers Decrease over Time Pseudoviral particles coding for the luciferase reporter gene and bearing the glycoproteins SARS-CoV-2 S (A, D, G, and H), SARS-CoV S (B, E, and I), or VSV-G (C and F) were used to infect 293T-ACE2 cells. Pseudoviruses were incubated with serial dilutions of samples from 10 COVID-19-negative or 106 COVID-19-positive patients (T1, T2, T3, T4, and convalescent) at 37°C for 1 h prior to infection of 293T-ACE2 cells. Infectivity at each dilution was assessed in duplicate and is shown as the percentage of infection without sera for each glycoprotein. Neutralization half maximal inhibitory serum dilution (ID 50 ) (G and I) and ID 80 (H) values were determined using a normalized non-linear regression using GraphPad Prism software. Undetectable measures are represented as white symbols. Neutralizer represent patients with an ID 50 over 100 (G and I) or an ID 80 (H). Statistical significance was tested using Mann-Whitney U tests (∗p < 0.05; ∗∗p < 0.01).

Article Snippet: Briefly, 293T cells were co-transfected with two packaging plasmids (pLP1 and pLP2), an envelope plasmid (pSVCMV-IN-VSV-G) and a lentiviral transfer plasmid coding for human ACE2 (pLenti-C-mGFP-P2A-Puro-ACE2) (OriGene).

Techniques: Luciferase, Incubation, Infection, Neutralization, Software, MANN-WHITNEY

Journal: Cell Reports Medicine

Article Title: Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike

doi: 10.1016/j.xcrm.2020.100126

Figure Lengend Snippet:

Article Snippet: Briefly, 293T cells were co-transfected with two packaging plasmids (pLP1 and pLP2), an envelope plasmid (pSVCMV-IN-VSV-G) and a lentiviral transfer plasmid coding for human ACE2 (pLenti-C-mGFP-P2A-Puro-ACE2) (OriGene).

Techniques: Recombinant, Modification, Saline, Western Blot, Lysis, Expressing, Transfection, Staining, Labeling, Plasmid Preparation, Software, Flow Cytometry

FIG. 3. Sp1/Sp3 binds 149- to 124-bp region of the Glut 3 gene. Mobility shift assays were carried out as explained under “Ex- perimental Procedures.” A, mobility shift assay. 32P-Labeled 149- to 124-bp GLUT 3 oligonucleotide (lane 1) was incubated with 5 g of nuclear extracts from N2A cells (lanes 2–4) and 1-day (1d) (lanes 5–7) and 21-day (21d) mouse brain nuclear extracts (lanes 8–10) and sub- jected to electrophoresis followed by autoradiography. The Sp1/Sp3 band shifts are shown. Addition of the anti-Sp1 antibody (lanes 3, 6, and 9) and anti-Sp3 antibody (lanes 4, 7, and 10) caused the supershift as shown. B, Western blot analysis. Presence of Sp1/Sp3 in these nuclear extracts is shown by Western blot analysis. Nuclear extracts (30 g) from N2A cells and 1- and 21-day-old mouse brain were subjected to immunoblot analysis as explained under “Experimental Procedures.” A representative blot showing a 105-kDa Sp1 protein (top panel) and 97- and 60-kDa bands for Sp3 (lower panel) is presented here. C, Sp1/Sp3 binding to 149 to 124 bp of the Glut 3 gene requires post-transla- tional modification. Mouse brain nuclear extracts from 1- and 21-day- old animals were used in mobility shift assays with the Sp1 consensus sequence (Promega) as probe (lanes 1 and 2). Lanes 3–7 contain the 149 to 119 bp (GT3 SP1). Binding reactions carried out using 1- and 21-day-old mouse brain nuclear extracts and human recombinant Sp1 (Promega) are shown in lanes 3–5 in respective order. Mixing experi- ments of the human recombinant Sp1 and nuclear extracts from 1- and 21-day-old mouse brain are shown in lanes 6 and 7.

Journal: Journal of Biological Chemistry

Article Title: Trans-activators Regulating Neuronal Glucose Transporter Isoform-3 Gene Expression in Mammalian Neurons

doi: 10.1074/jbc.m402735200

Figure Lengend Snippet: FIG. 3. Sp1/Sp3 binds 149- to 124-bp region of the Glut 3 gene. Mobility shift assays were carried out as explained under “Ex- perimental Procedures.” A, mobility shift assay. 32P-Labeled 149- to 124-bp GLUT 3 oligonucleotide (lane 1) was incubated with 5 g of nuclear extracts from N2A cells (lanes 2–4) and 1-day (1d) (lanes 5–7) and 21-day (21d) mouse brain nuclear extracts (lanes 8–10) and sub- jected to electrophoresis followed by autoradiography. The Sp1/Sp3 band shifts are shown. Addition of the anti-Sp1 antibody (lanes 3, 6, and 9) and anti-Sp3 antibody (lanes 4, 7, and 10) caused the supershift as shown. B, Western blot analysis. Presence of Sp1/Sp3 in these nuclear extracts is shown by Western blot analysis. Nuclear extracts (30 g) from N2A cells and 1- and 21-day-old mouse brain were subjected to immunoblot analysis as explained under “Experimental Procedures.” A representative blot showing a 105-kDa Sp1 protein (top panel) and 97- and 60-kDa bands for Sp3 (lower panel) is presented here. C, Sp1/Sp3 binding to 149 to 124 bp of the Glut 3 gene requires post-transla- tional modification. Mouse brain nuclear extracts from 1- and 21-day- old animals were used in mobility shift assays with the Sp1 consensus sequence (Promega) as probe (lanes 1 and 2). Lanes 3–7 contain the 149 to 119 bp (GT3 SP1). Binding reactions carried out using 1- and 21-day-old mouse brain nuclear extracts and human recombinant Sp1 (Promega) are shown in lanes 3–5 in respective order. Mixing experi- ments of the human recombinant Sp1 and nuclear extracts from 1- and 21-day-old mouse brain are shown in lanes 6 and 7.

Article Snippet: One hundred l of pre-cleared chromatin lysate was incubated with 1 g of either Sp3 (Santa Cruz Biotechnology, Santa Cruz, CA), CREB, or pCREB polyclonal antibody (Upstate Biotechnology, Inc.) and shaken on a nutator at 4 °C.

Techniques: Mobility Shift, Labeling, Incubation, Electrophoresis, Autoradiography, Western Blot, Binding Assay, Modification, Sequencing, Recombinant

FIG. 8. Confirmation of Sp3, CREB, and MSY-1 binding to the Glut 3 promoter region. A, ChIP demonstrates that Sp3 binds to the Glut 3 promoter region. PCR amplifications were performed on immunoprecipitated chromatin from N2A cells. PCR amplification product is seen in a 2% agarose gel as a 185-bp DNA fragment detected in the N2A cellular chromatin complexed with proteins that were immunoprecipitated with an antibody (Ab) against Sp3 (lane 3) using primers containing the Sp3-binding region of the Glut 3 gene (192 to 7 bp). Positive controls consisted of 10% of the total chromatin in the absence of immunoprecipitation (lane 2, positive control for PCR) and the mouse GLUT 3 (1553 to 331 bp) gene (control, lane 4). The negative control consisted of no primary antibody but only the secondary antibody (Ab, lane 5). Lane 1, DNA ladder. B, ChIP assay demonstrates that CREB/pCREB binds to the Glut 3 promoter region. PCR amplifications were performed on immunoprecipitated chromatin from N2A cells. PCR amplification product is seen in a 2% agarose gel as a 185-bp DNA fragment detected in the N2A cellular chromatin complexed with proteins that were immunoprecipitated with antibodies against either CREB (lane 4) or pCREB (lane 5) using primers containing the CREB binding region of the Glut 3 gene (192 to 7 bp). Negative controls consisted of dialysis buffer with no chromatin (Chromatin, lane 2), no primary antibody but staphylococcus A lysate (Ab, lane 3), whereas the positive control consisted of 10% of the total chromatin in the absence of immunoprecipitation (lane 6, positive control for PCR). Lane 1, DNA ladder. C, ChIP assay demonstrates no CREB/pCREB binding to the Glut 3 promoter in COS-7 cells. PCR amplification product is seen in the 2% agarose gel as a 185-bp DNA fragment detected only in the positive DNA control (control) which consisted of the mouse GLUT 3 (1553 to 331 bp) gene (lane 2, positive control for PCR), whereas no amplification product was noted in chromatin obtained from COS-7 (monkey kidney fibroblasts, which served as a negative cellular control) cells and immunoprecipitated with either the CREB (lane 3) or the pCREB (lane 4) antibodies or in 10% of the total chromatin in the absence of immunoprecipitation (lane 5). Lane 1, DNA ladder. D, ChIP assay demonstrates that MSY-1 binds to the Glut 3 promoter region. A 2% agarose gel demonstrates PCR amplifications that were performed on immunoprecipitated chromatin from N2A cells. PCRs targeted at amplifying DNA containing the MSY-1-binding site on the Glut 3 gene (89 to 260 bp) from immunoprecipitated protein complexed to chromatin in the presence of an anti-MSY-1 antibody (MSY-1 Ab, lane 4) revealed a 354-bp region. Negative control consisted of no primary antibody for MSY-1 but only the secondary antibody (Ab, lane 5). Positive controls consisted of 10% of the total chromatin (input, lane 3) and the mouse Glut 3 (1553 to 331 bp) gene (control, lane 2). Lane 1, DNA ladder. E, ChIP assay to demonstrate an interaction between CREB and MSY-1. PCR amplifications were performed on immunoprecipitated chromatin from N2A cells. A 2% agarose gel demonstrating PCR-amplified products containing the CREB and MSY-1 binding domains (185 bp) (lanes 2, 4, and 6) and only the MSY-1 binding domain (354 bp) (lanes 3, 5, and 7) region of the Glut 3 gene obtained by immunoprecipitating proteins complexed to chromatin with either the CREB antibody (lanes 2 and 3) and the MSY-1 antibody (lanes 4 and 5) but not with the IgG which served as the negative antibody control (lanes 6 and 7). Lane 1, DNA ladder. A 185-bp amplification product is seen when the CREB and MSY-1-binding sites containing region of the Glut 3 gene (192 to 7 bp) was amplified from chromatin that was immunoprecipitated with either the CREB (lane 2) or MSY-1 antibodies (lane 4). a 354-bp amplification product is seen when only the MSY-1-binding site containing region of the Glut 3 gene (89 to 260 bp) was amplified from chromatin that was immunoprecipitated with the MSY-1 antibody (lane 5) but not when the CREB antibody was used (lane 3). E, co-immunoprecipitation assay demonstrates an interaction between MSY-1 and CREB. Chromatin from N2A cells was immunoprecipitated with the MSY-1 antibody (lane 2), and this immunoprecipitated antibody-antigen-DNA complex and HeLa cell nuclear extract (lane 1, positive control) were subjected to Western blot analysis employing the CREB antibody (1:1000) which demonstrated an 43-kDa band.

Journal: Journal of Biological Chemistry

Article Title: Trans-activators Regulating Neuronal Glucose Transporter Isoform-3 Gene Expression in Mammalian Neurons

doi: 10.1074/jbc.m402735200

Figure Lengend Snippet: FIG. 8. Confirmation of Sp3, CREB, and MSY-1 binding to the Glut 3 promoter region. A, ChIP demonstrates that Sp3 binds to the Glut 3 promoter region. PCR amplifications were performed on immunoprecipitated chromatin from N2A cells. PCR amplification product is seen in a 2% agarose gel as a 185-bp DNA fragment detected in the N2A cellular chromatin complexed with proteins that were immunoprecipitated with an antibody (Ab) against Sp3 (lane 3) using primers containing the Sp3-binding region of the Glut 3 gene (192 to 7 bp). Positive controls consisted of 10% of the total chromatin in the absence of immunoprecipitation (lane 2, positive control for PCR) and the mouse GLUT 3 (1553 to 331 bp) gene (control, lane 4). The negative control consisted of no primary antibody but only the secondary antibody (Ab, lane 5). Lane 1, DNA ladder. B, ChIP assay demonstrates that CREB/pCREB binds to the Glut 3 promoter region. PCR amplifications were performed on immunoprecipitated chromatin from N2A cells. PCR amplification product is seen in a 2% agarose gel as a 185-bp DNA fragment detected in the N2A cellular chromatin complexed with proteins that were immunoprecipitated with antibodies against either CREB (lane 4) or pCREB (lane 5) using primers containing the CREB binding region of the Glut 3 gene (192 to 7 bp). Negative controls consisted of dialysis buffer with no chromatin (Chromatin, lane 2), no primary antibody but staphylococcus A lysate (Ab, lane 3), whereas the positive control consisted of 10% of the total chromatin in the absence of immunoprecipitation (lane 6, positive control for PCR). Lane 1, DNA ladder. C, ChIP assay demonstrates no CREB/pCREB binding to the Glut 3 promoter in COS-7 cells. PCR amplification product is seen in the 2% agarose gel as a 185-bp DNA fragment detected only in the positive DNA control (control) which consisted of the mouse GLUT 3 (1553 to 331 bp) gene (lane 2, positive control for PCR), whereas no amplification product was noted in chromatin obtained from COS-7 (monkey kidney fibroblasts, which served as a negative cellular control) cells and immunoprecipitated with either the CREB (lane 3) or the pCREB (lane 4) antibodies or in 10% of the total chromatin in the absence of immunoprecipitation (lane 5). Lane 1, DNA ladder. D, ChIP assay demonstrates that MSY-1 binds to the Glut 3 promoter region. A 2% agarose gel demonstrates PCR amplifications that were performed on immunoprecipitated chromatin from N2A cells. PCRs targeted at amplifying DNA containing the MSY-1-binding site on the Glut 3 gene (89 to 260 bp) from immunoprecipitated protein complexed to chromatin in the presence of an anti-MSY-1 antibody (MSY-1 Ab, lane 4) revealed a 354-bp region. Negative control consisted of no primary antibody for MSY-1 but only the secondary antibody (Ab, lane 5). Positive controls consisted of 10% of the total chromatin (input, lane 3) and the mouse Glut 3 (1553 to 331 bp) gene (control, lane 2). Lane 1, DNA ladder. E, ChIP assay to demonstrate an interaction between CREB and MSY-1. PCR amplifications were performed on immunoprecipitated chromatin from N2A cells. A 2% agarose gel demonstrating PCR-amplified products containing the CREB and MSY-1 binding domains (185 bp) (lanes 2, 4, and 6) and only the MSY-1 binding domain (354 bp) (lanes 3, 5, and 7) region of the Glut 3 gene obtained by immunoprecipitating proteins complexed to chromatin with either the CREB antibody (lanes 2 and 3) and the MSY-1 antibody (lanes 4 and 5) but not with the IgG which served as the negative antibody control (lanes 6 and 7). Lane 1, DNA ladder. A 185-bp amplification product is seen when the CREB and MSY-1-binding sites containing region of the Glut 3 gene (192 to 7 bp) was amplified from chromatin that was immunoprecipitated with either the CREB (lane 2) or MSY-1 antibodies (lane 4). a 354-bp amplification product is seen when only the MSY-1-binding site containing region of the Glut 3 gene (89 to 260 bp) was amplified from chromatin that was immunoprecipitated with the MSY-1 antibody (lane 5) but not when the CREB antibody was used (lane 3). E, co-immunoprecipitation assay demonstrates an interaction between MSY-1 and CREB. Chromatin from N2A cells was immunoprecipitated with the MSY-1 antibody (lane 2), and this immunoprecipitated antibody-antigen-DNA complex and HeLa cell nuclear extract (lane 1, positive control) were subjected to Western blot analysis employing the CREB antibody (1:1000) which demonstrated an 43-kDa band.

Article Snippet: One hundred l of pre-cleared chromatin lysate was incubated with 1 g of either Sp3 (Santa Cruz Biotechnology, Santa Cruz, CA), CREB, or pCREB polyclonal antibody (Upstate Biotechnology, Inc.) and shaken on a nutator at 4 °C.

Techniques: Binding Assay, Immunoprecipitation, Amplification, Agarose Gel Electrophoresis, Positive Control, Control, Negative Control, Co-Immunoprecipitation Assay, Western Blot